Company Overview and News

 
CBS Investors Can Press Forward With Waste Claims Over Redstone’s Pay - Bloomberg

4h bloomberg
Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.
Upvote Downvote

 
CBS Investors Can Proceed With Suit Over Redstone's Bonuses - Bloomberg

2018-04-19 bloomberg
Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.
Upvote Downvote

 
5 TV Stocks That Netflix Can’t Beat | InvestorPlace

2018-04-19 investorplace
There seems to be no letup in the powerful momentum with Netflix, Inc. (NASDAQ:NFLX). During the latest earnings report, revenues jumped by 43% and the company added 7.4 million new subscribers. The current membership base is now at 125 million.
Upvote Downvote

 
This Rebound Is A Lifeboat: Jump off Tesla Inc's Sinking Ship Now | InvestorPlace

2018-04-18 investorplace
Tesla Inc (NASDAQ:TSLA) had a disastrous month. In the company’s storied history, in fact, you could hardly think of a worse period for the company’s outlook. Just about everything that seemingly could go wrong is doing so now. And yet, Tesla stock remains resilient.
Upvote Downvote

 
FANG Is Leading The Charge - Cramer's Mad Money (4/17/18)

2018-04-18 seekingalpha
Stocks discussed on the in-depth session of Jim Cramer's Mad Money TV Program, Tuesday, April 17.
Upvote Downvote

 
Nielsen's top programs for April 9-15

2018-04-17 nzherald.co.nz
Prime-time viewership numbers compiled by Nielsen for April 9-15. Listings include the week's ranking and viewership.
Upvote Downvote

 
Budget U.S. airline popular with Canadian flyers under scrutiny for alleged mechanical faults

2018-04-17 cbc.ca
A budget airline that many British Columbians have used to vacation in destinations like California, Arizona and Las Vegas is under fire for alleged safety deficiencies.
Upvote Downvote

 
Las Vegas-based Allegiant Air under fire after 60 Minutes’ report raises safety concerns

2018-04-17 thestar
This copy is for your personal non-commercial use only. To order presentation-ready copies of Toronto Star content for distribution to colleagues, clients or customers, or inquire about permissions/licensing, please go to: www.TorontoStarReprints.com
Upvote Downvote

 
7 Sector ETFs to Own Now | InvestorPlace

2018-04-17 investorplace
I saw an article about sector exchange-traded funds recently. While the author was talking about the 11 different S&P 500 sectors and how you can trade each of them using State Street SPDRs, it got me wondering about all the other sector ETFs to own in the marketplace.
Upvote Downvote

 
Business Highlights

2018-04-16 nzherald.co.nz
PHILADELPHIA (AP) — Starbucks wants to add training for store managers on "unconscious bias," CEO Kevin Johnson said Monday, as activists held more protests at a Philadelphia store where two black men were arrested when employees said they were trespassing. Johnson, who has called the arrests "reprehensible," arrived in Philadelphia this weekend after video of the arrests gained traction online. He said he hopes to meet with the two men in the next couple of days and apologize to them face-to-face.
Upvote Downvote

 
Shares of Allegiant Air drop following CBS report on safety issues

2018-04-16 reuters
NEW YORK (Reuters) - Shares of Allegiant Travel Co (ALGT.O), the parent company of Allegiant Air, fell sharply in Monday afternoon trading, following a segment on CBS’ “60 Minutes” that alleged the airline suffered a high number of mechanical problems.
Upvote Downvote

 
Shares of Allegiant Air drop following CBS report on safety issues

2018-04-16 channelnewsasia
Shares of Allegiant Travel Co , the parent company of Allegiant Air, fell sharply in Monday afternoon trading, following a segment on CBS' "60 Minutes" that alleged the airline suffered a high number of mechanical problems.
Upvote Downvote

 
Netflix: Mania Continues Despite Reality Setting In

2018-04-16 seekingalpha
Netflix has become your run of the mill content producer, and the Comcast deal is the proof.
Upvote Downvote

 
Despite Investor Concerns, Netflix, Inc. Stock Is Worth the Gamble | InvestorPlace

2018-04-13 investorplace
Netflix, Inc. (NASDAQ:NFLX) has had a bumpy month after its share price broke above $320 and then swiftly dipped down to $280 within a matter of weeks. But the market overall has been shaky so far this year, especially for tech stocks which have been weighed down by bad press and worries about unreasonable valuations. NFLX stock has since made its way back above $300 per share, but that doesn’t mean you’ve totally missed the boat — Netflix is a solid long-term pick with a lot of growth potential as the streaming space matures.
Upvote Downvote

 
Here Is How It All Could Go Wrong for Netflix, Inc. Stock

2018-04-12 investorplace
To be clear, I would not recommend a short of Netflix, Inc. (NASDAQ:NFLX) stock for a number of reasons. Netflix stock isn’t cheap, and some hardy souls are making that trade. Nearly 5% of the float of NFLX stock is sold short at the moment.
Upvote Downvote

Related Articles

RDHL: Redhill Biopharma Ltd (OTC:REDIF) Analysis and Research Report

2018-04-18 - Asif

History and Development of the Company The company's legal and commercial name is RedHill Biopharma Ltd. The company's company was incorporated on August 3, 2009, and was registered as a private company limited by shares under the laws of the State of Israel. The company's principal executive offices are located at 21 Ha’arba’a Street, Tel Aviv, Israel. In February 2011, the company completed its initial public offering in Israel, pursuant to which the company issued 14,302,300 Ordinary Shares, and 7,151,150 tradable Series 1 Warrants to purchase 7,151,150 Ordinary Shares for aggregate gross proceeds of approximately $14 million. On December 27, 2012, the company completed the listing of its ADSs on the NASDAQ Capital Market. The company's Ordinary Shares are traded on the Tel-Aviv Stock Exchange under the symbol “RDHL,” and its ADSs are traded on the NASDAQ Capital Market under the same symbol "RDHL". The company's capital expenditures for the years ended December 31, 2...

SCYX: SCYNEXIS Analysis and Research Report

2018-04-16 - Asif

Overview SCYNEXIS, Inc. is a biotechnology company committed to positively impacting the lives of patients suffering from difficult-to-treat and often life-threatening infections by delivering innovative anti-infective therapies. SCYNEXIS is developing its lead product candidate, SCY-078, as the first representative of a novel oral and intravenous (IV) triterpenoid antifungal family in clinical development for the treatment of several serious fungal infections, including invasive candidiasis, invasive aspergillosis, refractory invasive fungal infections and vulvovaginal candidiasis (VVC). SCY-078 is a structurally distinct glucan synthase inhibitor that has been shown to be effective in vitro and in vivo against a broad range of human fungi pathogens such as Candida and Aspergillus species, including multidrug-resistant strains, as well as Pneumocystis species. Candida and Aspergillus species are the fungi responsible for approximately 85% of all invasive fungal infections in t...

ENRT: Enertopia Corp (CNSX:TOP) Analysis and Research Report

2018-04-16 - Asif

Business History Enertopia Corp. was formed on November 24, 2004 under the laws of the State of Nevada and commenced operations on November 24, 2004. From inception until April 2010, the company were primarily engaged in the acquisition and exploration of natural resource properties. Beginning in April 2010, the company began its entry into the renewable energy sector by purchasing an interest in a solar thermal design and installation company. In late summer 2013, the company began its entry into medicinal marijuana business. During its 2014 fiscal year end its activities in the clean energy sector were discontinued. During fiscal 2015 its activities in the Medicinal Marijuana sector were discontinued. During fiscal 2016 its activities in the Women’s personal healthcare sector were discontinued. The Company is actively pursuing business opportunities in the resource sector, whereby the company signed a definitive agreement for a Lithium Brine Project in May 2016. In May ...

FB: Facebook Analysis and Research Report

2018-04-15 - Asif

Overview The company's mission is to give people the power to build community and bring the world closer together. The company's top priority is to build useful and engaging products that enable people to connect and share with friends and family through mobile devices, personal computers, and other surfaces. The company also help people discover and learn about what is going on in the world around them, enable people to share their opinions, ideas, photos and videos, and other activities with audiences ranging from their closest friends to the public at large, and stay connected everywhere by accessing its products, including: Facebook enables people to connect, share, discover, and communicate with each other on mobile devices and personal computers. There are a number of different ways to engage with people on Facebook, the most important of which is News Feed which displays an algorithmically-ranked series of stories and advertisements individualized for each pers...

VSTM: Verastem Analysis and Research Report

2018-04-12 - Asif

Business Overview Verastem is a biopharmaceutical company focused on developing and commercializing drugs to improve the survival and quality of life of cancer patients. The company's most advanced product candidates, duvelisib and defactinib, utilize a multi-faceted approach to treat cancers originating either in the blood or major organ systems. Verastem is currently evaluating these compounds in both preclinical and clinical studies as potential therapies for certain cancers, including leukemia, lymphoma, lung cancer, ovarian cancer, mesothelioma, and pancreatic cancer. The company believe that these compounds may be beneficial as therapeutics either as single agents or when used in combination with immuno-oncology agents or other current and emerging standard of care treatments in aggressive cancers that are poorly served by currently available therapies. Duvelisib targets the Phosphoinositide 3-kinase (PI3K) signaling pathway. The PI3K signaling pathway plays a centr...

CUSIP: 124857202